Skip to main content ( press enter )

Search

Reset filter
Displaying results 336 - 342 of 2554
Improving outcomes for people with inoperable renal cell carcinoma
Long-term data shows the tremendous benefit provided by a new type of radiotherapy for people with inoperable renal cell carcinoma (kidney cancer) with remission sustained over five years. Long-term data shows the tremendous... Read more
Prostate Cancer Foundation awards Dr Renu Eapen the Young Investigator Award for 2022
The Prostate Cancer Foundation (PCF) in the United States has awarded Peter Mac’s Dr Renu Eapen with its prestigious Michael & Lori Milken-PCF Young Investigator Award. The Prostate Cancer Foundation (PCF) in the... Read more
Seven Peter Mac Researchers awarded Victorian Cancer Agency Fellowships
Seven researchers at Peter Mac have been awarded 2022 Victorian Cancer Agency (VCA)’s Early and Mid-Career Fellowships.The fellowships are designed to help support promising early career researchers who are undertaking... Read more
New brain cancer research initiative puts Melbourne at the fore
“Brain-POP” will place Melbourne at the fore of brain cancer research and drive development of more targeted and personalised treatments. The world-first clinical trial platform will hand scientists a powerful new tool... Read more
Learn about our genetic counsellors
In recognition of Genetic Counsellor Awareness Day, hear from Peter Mac’s Dr Laura Forrest, associate genetic counsellor and senior research fellow who leads the Psychosocial Cancer Genomics Research team, about... Read more
Peter Mac, Cartherics developing a new CAR T-cell therapy
Peter MacCallum Cancer Centre and Cartherics Pty Ltd have entered into a Collaborative Development Program Agreement (CDPA) to develop Cartherics’ proprietary autologous CAR T-cell therapy (CTH-001) for the... Read more
Back to top